Anbio Biotechnology (NNNN) Non-Current Assets (2023 - 2024)
Anbio Biotechnology's quarterly Non-Current Assets came in at $387440.0 in Q4 2024, up 523.53% year-on-year from $62137.0 in Q1 2024, and up 523.53% quarter-over-quarter from $62137.0 in Q4 2023.
Anbio Biotechnology has reported Non-Current Assets for 2 years, with the latest figure at $387440.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 11.30 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 42.82 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 4.72 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 2.28 Bn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 10.51 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 10.29 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 3.66 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.00 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 3.33 Bn |
| 10 | Anbio Biotechnology | 1.32 Bn | 1.31 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 387,440.00 |
| Dec 31, 2023 | 62,137.00 |